Corydaline and Midazolam Hydroxylation: Preincubation Changed the Laboratory Signal

A human-liver-microsome study found time-dependent inhibition of midazolam hydroxylation with corydaline.

What the assay tested

Corydaline is an alkaloid associated with Corydalis tubers. The investigators tested several CYP and glucuronidation pathways using analytical probe reactions. Midazolam hydroxylation declined with increasing preincubation time and concentration, making the timing of the laboratory incubation relevant to the observed inhibition.

From enzyme activity to a patient

Microsomes lack the whole-body processes governing absorption, protein binding, distribution, and elimination. The study did not administer corydaline with midazolam to people or measure sedation. It therefore identifies an interaction hypothesis, not a demonstrated magnitude of clinical exposure change. A reported herbal product also may not contain the same corydaline amount used in an assay. The useful forensic question is whether a plausible inhibitor and sufficient exposure existed, while retaining the distinction between an in-vitro signal and established patient-level causation.

Source paper

Original analysis of the supplied journal article, identified as PMC6264278.

Related research

• Cat Midazolam–Pethidine Study Changed Dose as Well as Administration Route
• Clonidine’s Midazolam-Sparing Signal Depended on Adjustment in a Small ICU Trial